Disease-modifying effect, safety and optimal dose of oral semaglutide tablets for patients with Parkinson's disease (MOST-ABLE study): protocol for a randomised, double-blind, placebo-controlled study.

Saved in:
Bibliographic Details
Title: Disease-modifying effect, safety and optimal dose of oral semaglutide tablets for patients with Parkinson's disease (MOST-ABLE study): protocol for a randomised, double-blind, placebo-controlled study.
Authors: Kimura Y; Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan y-kimura@neurol.med.osaka-u.ac.jp mochizuki.hideki.yj@mail.hosp.go.jp., Koda T; Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan., Kurakami H; Institute for Clinical and Translational Science, Nara Medical University, Kashihara, Japan., Sakamoto S; Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan., Iwasaki K; Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan., Asai K; Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan., Ge L; Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan., Kato H; Department of Advanced Radioisotope Medicine, Institute for Radiation Sciences, The University of Osaka, Suita, Japan., Tsuboi T; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Matsukawa N; Department of Neurology and Neuroscience, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Kano O; Department of Neurology, Toho University Faculty of Medicine, Tokyo, Japan., Matsuse D; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of Neurology, Kyushu University Hospital, Fukuoka, Japan., Tomiyama M; Department of Neurology, Hirosaki University School of Medicine, Hirosaki, Japan., Yokoe M; Toyonaka Municipal Hospital, Toyonaka, Japan., Nagai Y; Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Japan., Mochizuki H; Department of Neurology, The University of Osaka Graduate School of Medicine, Suita, Japan y-kimura@neurol.med.osaka-u.ac.jp mochizuki.hideki.yj@mail.hosp.go.jp.; National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.
Source: BMJ open [BMJ Open] 2025 Dec 24; Vol. 15 (12), pp. e112318. Date of Electronic Publication: 2025 Dec 24.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2025-112318